XTX Topco’s Lisata Therapeutics LSTA Stock Holding History

XTX Topco’s Portfolio LSTA Stock Details LSTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-11,111	Closed	-$29.1K	–	3592
2025 Q3	$29.1K	Buy	+11,111	New	+$27.9K	﹤0.01%	2267

Other funds holding LSTA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BCM

BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

GSC

Ground Swell Capital Folly Beach, South Carolina $92.6M AUM 41.64% 1-Year Est. Return

Cerity Partners New York $70.8B AUM 21.68% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

XTX Topco's LSTA Position: Q4 2025 in Review

XTX Topco sold out of Lisata Therapeutics (LSTA) in Q4 2025, closing a stake of 11,111 shares — an estimated $29.1K sold.

XTX Topco first reported a position in LSTA in Q3 2025 and held it in 1 quarter. The position peaked at $29.1K in Q3 2025. 25 funds tracked by Wall St. Rank hold LSTA as of Q4 2025.

XTX Topco reported no remaining Lisata Therapeutics position as of Q4 2025 after selling out during the quarter.
XTX Topco sold 11,111 Lisata Therapeutics shares in Q4 2025, an estimated $29.1K.
XTX Topco first reported a position in Lisata Therapeutics in Q3 2025 and held it in 1 quarter.
XTX Topco's Lisata Therapeutics position peaked at $29.1K in Q3 2025.
25 funds tracked by Wall St. Rank held Lisata Therapeutics as of Q4 2025.

Based on XTX Topco's 13F filing for Q4 2025, filed 17 Feb 2026.